According to Immunome's latest financial reports the company's current EPS (TTM) is -HK$17.07. In 2022 the company made an earnings per share (EPS) of -HK$23.97 a decrease over its 2021 EPS that were of -HK$16.52.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$17.24 | -28.08% |
2022 | -HK$23.97 | 45.07% |
2021 | -HK$16.52 | 3.38% |
2020 | -HK$15.98 |